J04B Drugs for treatment of lepra
ATC group of level 3 – pharmacological subgroup · in plain English: medicines for tuberculosis
This site has the patient leaflet or the SPC of 5 medicines in this group and its subgroups.
- 4 prescription only (POM)
Active substance: Dapsone – all medicines with this substance, also in combinations.
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J04 Antimycobacterials 44 medicines
-
J04B Drugs for treatment of lepra 5 medicines
- J04BA Drugs for treatment of lepra 5 medicines
-
J04B Drugs for treatment of lepra 5 medicines
- J04 Antimycobacterials 44 medicines
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Dapsone 100 mg tablets SPC (J04BA02 dapsone) | Prescription only (POM) |
| Dapsone 25 mg tablets SPC (J04BA02 dapsone) | – |
| Dapsone 50 mg tablets SPC (J04BA02 dapsone) | Prescription only (POM) |
| Dapsone tablets BP 100 mg SPC (J04BA02 dapsone) | Prescription only (POM) |
| Dapsone tablets BP 50 mg SPC (J04BA02 dapsone) | Prescription only (POM) |
Other groups of the same level
- J04A Drugs for treatment of tuberculosis 38 medicines
Other names of the ATC group
- Czech: J04B Léčiva k terapii lepry
- French: J04B médicaments antilépreux
- German: J04B MITTEL ZUR BEHANDLUNG DER LEPRA
- Spanish: J04B MEDICAMENTOS CONTRA LA LEPRA
- German: J04B MITTEL ZUR BEHANDLUNG DER LEPRA
- Polish: J04B Leki stosowane w leczeniu trądu
- Turkish: J04B LEPRA TEDAVİSİ İÇİN İLAÇLAR
- Portuguese (Brazil): J04B FÁRMACOS USADOS NO TRATAMENTO DA LEPRA
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J04B
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
